# OnCo record axcynsis-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/axcynsis-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "axcynsis-therapeutics" ;
  schema:name "Axcynsis Therapeutics"@en ;
  schema:alternateName "Axcynsis Therapeutics Pte Ltd"@en, "Tetris Therapeutics"@en ;
  schema:description "Axcynsis Therapeutics makes antibody-drug conjugates, antibodies that carry a cell-killing drug to cancer cells; its first one, aimed at the protein CLDN6, is in an early trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/axcynsis-therapeutics/>, <https://axcynsis.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://axcynsis.com/>, <https://axcynsis.com/pipeline/>, <https://axcynsis.com/phase-1-clinical-trial/>, <https://clinicaltrials.gov/study/NCT06809114> ;
  schema:addressCountry "SG" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/bispecific-adc/>, <https://onco.cc/technologies/dual-payload-adc/> ;
  onco:targets <https://onco.cc/targets/cldn6/>, <https://onco.cc/targets/dll3/>, <https://onco.cc/targets/ror1/>, <https://onco.cc/targets/her2/> .